Stay updated on Nivolumab Ipilimumab in CKS Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab in CKS Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. The page content and study details appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-05T18:45:42.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-12T02:15:21.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.0 to v3.4.1. No changes to the study details, eligibility criteria, or other user-visible content were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:26:14.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The additions and deletions are UI-level changes that do not affect core study data such as eligibility, outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T20:29:36.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The only visible change is the revision update from v3.3.3 to v3.3.4, with no edits to the study content or page behavior. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:12:53.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page shows an update to the site footer/release notes: Revision: v3.3.3 was added, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:12:27.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab in CKS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.